Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease

NCT04542967 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

Severe COVID-19 Disease

Interventions

BIOLOGICAL: Biological

Sponsor

Hospital Central Militar